Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release Feb 24 2026

· Issued by Caplin Point Laboratories Limited

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the Sodium Phosphates Injection USP "

View Attachment

Earlier from Caplin Point Laboratories

All Caplin Point Laboratories news releases